Healthcare heavy-weight stock CSL Limited peaked 25/07/16 at $121.25, but the share-price has since been in decline to reach a low of $91.62 on the 12th December 2016.
There has been a strong rebound since then with the share price penetrating back up through support at about $98.50.
This impulsive move is a bullish signal for further gains with the previous high at $121 a likely target.
Categories: Chart Review
AGL’s accelerated decarbonization plan impacts 1H 2022/3 profit result. 
Are there headwinds just ahead for the Aussie stock market? 
Is it a good time for retirees to buy Wesfarmers? 
Improve your decision making with multiple technical tools 
Technically Speaking 
Leave a Reply